Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Feb;67(2):222–225. doi: 10.1038/bjc.1993.43

The clonogenic growth of advanced breast tumour lesions adds no value to that of established clinical prognosticators for survival.

V Hug 1, A Polyzos 1, S Tucker 1, H Thames 1
PMCID: PMC1968185  PMID: 8431355

Abstract

We measured the clonogenic growth of 110 breast cancer samples obtained from 107 patients with advanced disease. We determined clonogenicity under conventional conditions and under conditions supplemented with growth factors and hormones that target breast tissue. After a median follow-up period of 6 years we analyzed our data to determine if and to what degree clonogenic growth of metastatic breast tumours was related to the survival of patients. We found that tumour clonogenicity and patient survival correlated weakly, particularly if compared to the strong correlations of patient survival with either performance status or tumour bulk. Furthermore, an association between tumour clonogenicity and patient survival was visible only for clonogenicity that was determined under hormone-supplemented conditions, and only for tumour lesions that formed 50 or more colonies per 500,000 cells cultured. Thus, we conclude that clonogenic growth of breast tumour samples incompletely reflects the tumour features that determine the course of advanced disease.

Full text

PDF
222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arteaga C. L., Tandon A. K., Von Hoff D. D., Osborne C. K. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res. 1988 Jul 15;48(14):3898–3904. [PubMed] [Google Scholar]
  2. Briozzo P., Morisset M., Capony F., Rougeot C., Rochefort H. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res. 1988 Jul 1;48(13):3688–3692. [PubMed] [Google Scholar]
  3. Brock W. A., Baker F. L., Peters L. J. Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability. Int J Radiat Biol. 1989 Nov;56(5):751–760. doi: 10.1080/09553008914552001. [DOI] [PubMed] [Google Scholar]
  4. Cormier E. M., Wolf M. F., Jordan V. C. Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth. Cancer Res. 1989 Feb 1;49(3):576–580. [PubMed] [Google Scholar]
  5. Gioanni J., Farges M. F., Duplay H., Hery M., Zanghellini E., Schneider M., Mazeau C., Namer M., Courdi A. In vitro clonogenicity in relation to kinetic and clinicopathological features of breast cancer. Bull Cancer. 1988;75(3):285–290. [PubMed] [Google Scholar]
  6. Hug V., Haynes M., Rashid R., Spitzer G., Blumenschen G., Hortobagyi G. Improved culture conditions for clonogenic growth of primary human breast tumours. Br J Cancer. 1984 Aug;50(2):207–213. doi: 10.1038/bjc.1984.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Huot J., Aubin J., Goulet F., Goyette R. Flow cytometric analysis of human breast tumors and assessment of in vitro chemosensitivity by clonogenic assays. Cell Biol Toxicol. 1990 Jan;6(1):81–94. doi: 10.1007/BF00135028. [DOI] [PubMed] [Google Scholar]
  8. Mattox D. E., Von Hoff D. D. In vitro stem cell assay in head and neck squamous carcinoma. Am J Surg. 1980 Oct;140(4):527–530. doi: 10.1016/0002-9610(80)90205-6. [DOI] [PubMed] [Google Scholar]
  9. Nomura Y., Tashiro H., Hisamatsu K. In vitro clonogenic growth and metastatic potential of human operable breast cancer. Cancer Res. 1989 Oct 1;49(19):5288–5293. [PubMed] [Google Scholar]
  10. Osborne C. K., Coronado E. B., Kitten L. J., Arteaga C. I., Fuqua S. A., Ramasharma K., Marshall M., Li C. H. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol. 1989 Nov;3(11):1701–1709. doi: 10.1210/mend-3-11-1701. [DOI] [PubMed] [Google Scholar]
  11. Pourreau-Schneider N., Delori P., Boutière B., Arnoux D., George F., Sampol J., Martin P. M. Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231. J Natl Cancer Inst. 1989 Feb 15;81(4):259–266. doi: 10.1093/jnci/81.4.259. [DOI] [PubMed] [Google Scholar]
  12. Ruckdeschel J. C., Carney D. N., Oie H. K., Russell E. K., Gazdar A. F. In vitro chemosensitivity of human lung cancer cell lines. Cancer Treat Rep. 1987 Jul-Aug;71(7-8):697–704. [PubMed] [Google Scholar]
  13. Smallwood J. A., Morgan G. R., Cooper A., Kirkham N., Williams C. J., Whitehouse J. M., Taylor I. Correlations between clonogenicity and prognostic factors in human breast cancer. Br J Surg. 1984 Feb;71(2):109–111. doi: 10.1002/bjs.1800710209. [DOI] [PubMed] [Google Scholar]
  14. Trotter G. A., Morgan G. R., Goeting N., Cooper A. J., Taylor I. Prognostic factors and in vitro cytotoxic sensitivity in colorectal cancer. Br J Surg. 1984 Dec;71(12):944–946. doi: 10.1002/bjs.1800711211. [DOI] [PubMed] [Google Scholar]
  15. Von Hoff D. D., Casper J., Bradley E., Sandbach J., Jones D., Makuch R. Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. Am J Med. 1981 May;70(5):1027–1041. doi: 10.1016/0002-9343(81)90859-7. [DOI] [PubMed] [Google Scholar]
  16. Von Hoff D. D., Clark G. M., Stogdill B. J., Sarosdy M. F., O'Brien M. T., Casper J. T., Mattox D. E., Page C. P., Cruz A. B., Sandbach J. F. Prospective clinical trial of a human tumor cloning system. Cancer Res. 1983 Apr;43(4):1926–1931. [PubMed] [Google Scholar]
  17. Von Hoff D. D., Cowan J., Harris G., Reisdorf G. Human tumor cloning: feasibility and clinical correlations. Cancer Chemother Pharmacol. 1981;6(3):265–271. doi: 10.1007/BF00256979. [DOI] [PubMed] [Google Scholar]
  18. Von Hoff D. D., Forseth B. J., Huong M., Buchok J. B., Lathan B. Improved plating efficiencies for human tumors cloned in capillary tubes versus Petri dishes. Cancer Res. 1986 Aug;46(8):4012–4017. [PubMed] [Google Scholar]
  19. Yee D., Cullen K. J., Paik S., Perdue J. F., Hampton B., Schwartz A., Lippman M. E., Rosen N. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res. 1988 Dec 1;48(23):6691–6696. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES